BCAS2 anticorps (C-Term)

N° du produit ABIN6991284

Détail du produit anti-BCAS2 anticorps

Antigène: BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))

Épitope: C-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCAS2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Purification: BCAS2 Antibody is affinity chromatography purified via peptide column.

Immunogène: BCAS2 antibody was raised against a 14 amino acid synthetic peptide near the carboxy terminus of human BCAS2. The immunogen is located within the last 50 amino acids of BCAS2.

Isotype: IgG

Information d'application

Indications d'application: BCAS2 antibody can be used for detection of BCAS2 by Western blot at 0.5 - 1 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: BCAS2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: BCAS2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur BCAS2

Antigène: BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))

Autre désignation: BCAS2 (BCAS2 Produits)

Synonymes: anticorps DAM1, anticorps SPF27, anticorps Snt309, anticorps 6430539P16Rik, anticorps AI132645, anticorps C76366, anticorps C80030, anticorps BCAS2, anticorps cb302, anticorps zgc:101730, anticorps BCAS2, pre-mRNA processing factor, anticorps breast carcinoma amplified sequence 2, anticorps breast carcinoma amplified sequence 2 L homeolog, anticorps BCAS2, anticorps Bcas2, anticorps bcas2, anticorps bcas2.L, anticorps CpipJ_CPIJ003889

Sujet: BCAS2 Antibody: BCAS2 was identified through differential display analysis as an mRNA species that was overexpressed in MCF7 and BT-20 breast cancer cell lines. The chromosomal region containing this gene, 1p13.3021, is amplified in these cells lines. BCAS2 is a transcriptional cofactor that enhances estrogen receptor-mediated gene expression, and directly interacts with the tumor suppressor p53 to reduce p53 transcriptional activity by reducing p53 protein level in the absence of DNA damage. Deprivation of BCAS2 through RNA inhibition induces apoptosis in p53-wild type cells, but causes G2-M arrest in p53-null or -mutant cells, this effect was reversed with the expression of ectopic BCAS2. BCAS2 may thus be potentially useful as a therapeutic target in the treatment of cancer.

ID gène: 10286

UniProt: O75934